Ronni Fuchs

Ronni Fuchs

Troutman Pepper

Contact
View Bio
RSS

Latest Posts › Investigational New Drug Application (IND)

Share:

FDA Draft Guidance Instructs Sponsors on Content and Timing of Diversity Plans for Clinical Trials

For several years, FDA has advanced a policy of increasing diversity in clinical trial populations. During that time, FDA issued broad policy statements, as well as guidance on improved data collection and steps sponsors...more

6/15/2022  /  Clinical Trials , Diversity , Draft Guidance , Food and Drug Administration (FDA) , Investigational New Drug Application (IND)
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide